Aurinia Pharmaceuticals Inc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Aurinia Pharmaceuticals Inc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits | Quantisnow